Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03126539 · ClinicalTrials.gov registry record · Phase 2
Effect of Topical Sulforaphane on Skin Fragility Seen in Skin Aging and With Ultraviolet Exposure
A Phase 2 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT03126539: Clinical Trial Phase 2 study, sponsored by Johns Hopkins University.
NCT03126539 is a Phase 2 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03126539, a Phase 2 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study aims to compare the expression of keratins before and after application of sulforaphane (SF) to determine whether this agent alters skin fragility seen in both intrinsic and extrinsic skin aging and UV light exposure.
Interventions
- DRUG Sulforaphane
- RADIATION Narrow-band Ultraviolet B exposure
- PROCEDURE 4 mm skin punch biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2019-01-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03126539
The ClinicalTrials.gov registry entry for NCT03126539 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sulforaphane is the first listed.
NCT03126539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03126539 about?
NCT03126539 is a clinical study titled "Effect of Topical Sulforaphane on Skin Fragility Seen in Skin Aging and With Ultraviolet Exposure". This study aims to compare the expression of keratins before and after application of sulforaphane (SF) to determine whether this agent alters skin fragility seen in both intrinsic and extrinsic skin aging and UV light exposure.
What is the current status of trial NCT03126539?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2017-09-15. Estimated completion is 2019-01-18.
What interventions are being tested in trial NCT03126539?
The interventions under investigation include: Sulforaphane (DRUG), Narrow-band Ultraviolet B exposure (RADIATION), 4 mm skin punch biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT03126539?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.